Achala Pharmaceuticals Pvt Ltd
Produces and sells a variety of baking ingredients and products since 1979.
1979 | Thane, Maharashtra (India) | Active
Achala Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 9.50 M
- Paid Up Capital ₹ 7.09 M
- Company Age 46 Year, 13 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -18.70%
- Profit Growth -296.12%
- Ebitda 28.41%
- Net Worth -4.77%
- Total Assets -4.63%
About Achala Pharmaceuticals
Achala Pharmaceuticals Pvt Ltd (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 February 1979 and has a history of 46 years. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.50 M and a paid-up capital of Rs 7.09 M, as per Ministry of Corporate Affairs (MCA) records.
Arvind Kunder and Radha Kunder serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U99999MH1979PTC021011
- Company No.
021011
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 1979
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Food and Beverages
What products or services does Achala Pharmaceuticals Pvt Ltd offer?
Achala Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Cereals & Food Grains, Flours, Bakery & Confectionery Products, Confectionery Ingredients, Candy & Jelly, Orange Jelly, Bakery Ingredients, Baking Powder.
Who are the key members and board of directors at Achala Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Kunder  | Director | 15-Feb-1979 | Current |
| Radha Kunder | Director | 15-Feb-1979 | Current |
Financial Performance of Achala Pharmaceuticals.
Achala Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 18.7% decrease. The company also saw a substantial fall in profitability, with a 296.12% decrease in profit. The company's net worth dipped by a decrease of 4.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Achala Pharmaceuticals?
In 2021, Achala Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Achala Pharmaceuticals?
Unlock and access historical data on people associated with Achala Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Achala Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Achala Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.